Skip to content

Safety and efficacy of low central venous pressure combined with ultrasound-guided thoracic paravertebral block in laparoscopic anatomical left hemihepatectomy

Safety and efficacy of low central venous pressure combined with ultrasound-guided thoracic paravertebral block in laparoscopic anatomical left hemihepatectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044281
Enrollment
Unknown
Registered
2021-03-14
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver disease

Interventions

Two groups:low central venous pressure combined with ultrasound-guided thoracic paravertebral block versus low central venous pressure

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: This study was approved by the medical ethics committee of the hospital, and informed consent was signed with patients and their families. Eighty patients aged 20-65 years old underwent laparoscopic anatomical left hemihepatectomy under general anesthesia. ASA grade I-II, heart, lung, liver, kidney and coagulation function were normal. Child push grade A or B had no history of ropivacaine allergy. No drugs affecting nervous system were used before operation.

Exclusion criteria

Exclusion criteria: Those allergic to ropivacaine, opioids or non steroidal anti-inflammatory drugs; those who had used pain medication within 24 hours before operation, those with mental disorders and those with preoperative body mass index (BMI) > 40 kg/m2.

Design outcomes

Secondary

MeasureTime frame
postoperative VAS pain score, the number of self-controlled analgesia compressions, the recovery rate of postoperative analgesia, the total dosage of propofol and remifentanil during operation, and the anesthetic effect;

Countries

China

Contacts

Public ContactDanfeng Wang

Fujian Provincial Hospital

251487848@qq.com+86 13906920551

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026